We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biosite's Acetaminophen Detection Test Receives 510(k)
Biosite's Acetaminophen Detection Test Receives 510(k)
March 4, 2005
The FDA has given 510(k) clearance to Biosite’s Triage TOX Drug Screen with Acetaminophen, the first drug screen to include a rapid, point-of-care test for the qualitative detection of acetaminophen in urine.